130 related articles for article (PubMed ID: 21282053)
1. Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P.
Zhang W; Song J; Mu L; Zhang B; Liu L; Xing Y; Wang K; Li Z; Wang R
Bioorg Med Chem Lett; 2011 Mar; 21(5):1452-5. PubMed ID: 21282053
[TBL] [Abstract][Full Text] [Related]
2. A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation.
Moon C; Kwon YM; Lee WK; Park YJ; Chang LC; Yang VC
J Biomed Mater Res A; 2008 Jan; 84(1):238-46. PubMed ID: 17607767
[TBL] [Abstract][Full Text] [Related]
3. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
5. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
6. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
7. Polymeric phosphorylcholine-camptothecin conjugates prepared by controlled free radical polymerization and click chemistry.
Chen X; McRae S; Parelkar S; Emrick T
Bioconjug Chem; 2009 Dec; 20(12):2331-41. PubMed ID: 19899739
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new camptothecin analogs with improved antitumor activities.
Niizuma S; Tsukazaki M; Suda H; Murata T; Ohwada J; Ozawa S; Fukuda H; Murasaki C; Kohchi M; Morikami K; Yoshinari K; Endo M; Ura M; Tanimura H; Miyazaki Y; Takasuka T; Kawashima A; Nanba E; Nakano K; Ogawa K; Kobayashi K; Okabe H; Umeda I; Shimma N
Bioorg Med Chem Lett; 2009 Apr; 19(7):2018-21. PubMed ID: 19254843
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and solid tumors.
Ying V; Haverstick K; Page RL; Saltzman WM
J Biomater Sci Polym Ed; 2007; 18(10):1283-99. PubMed ID: 17939886
[TBL] [Abstract][Full Text] [Related]
10. First synthesis of novel spin-labeled derivatives of camptothecin as potential antineoplastic agents.
Liu YQ; Tian X; Yang L; Zhan ZC
Eur J Med Chem; 2008 Nov; 43(11):2610-4. PubMed ID: 18313176
[TBL] [Abstract][Full Text] [Related]
11. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.
Zhang L; Xia J; Zhao Q; Liu L; Zhang Z
Small; 2010 Feb; 6(4):537-44. PubMed ID: 20033930
[TBL] [Abstract][Full Text] [Related]
12. Design and one-pot synthesis of new 7-acyl camptothecin derivatives as potent cytotoxic agents.
Liu YQ; Dai W; Wang CY; Morris-Natschke SL; Zhou XW; Yang L; Yang XM; Li WQ; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7659-61. PubMed ID: 23102893
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
14. Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy.
Moon SJ; Govindan SV; Cardillo TM; D'Souza CA; Hansen HJ; Goldenberg DM
J Med Chem; 2008 Nov; 51(21):6916-26. PubMed ID: 18939816
[TBL] [Abstract][Full Text] [Related]
15. Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues.
Lavergne O; Lesueur-Ginot L; Pla Rodas F; Kasprzyk PG; Pommier J; Demarquay D; Prévost G; Ulibarri G; Rolland A; Schiano-Liberatore AM; Harnett J; Pons D; Camara J; Bigg DC
J Med Chem; 1998 Dec; 41(27):5410-9. PubMed ID: 9876111
[TBL] [Abstract][Full Text] [Related]
16. Camptothecin conjugated with DNA minor-groove binder netropsin: enhanced lactone stability, inhibition of human DNA topoisomerase I and antiproliferative activity.
Sukhanova A; Grokhovsky S; Zhuze A; Devy J; Pluot M; Oleinikov V; Nabiev I
Anticancer Res; 2003; 23(3B):2609-15. PubMed ID: 12894548
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
18. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles.
Kim C; Kim S; Oh WK; Choi M; Jang J
Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin.
Bhatt R; de Vries P; Tulinsky J; Bellamy G; Baker B; Singer JW; Klein P
J Med Chem; 2003 Jan; 46(1):190-3. PubMed ID: 12502373
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.
Paranjpe PV; Chen Y; Kholodovych V; Welsh W; Stein S; Sinko PJ
J Control Release; 2004 Nov; 100(2):275-92. PubMed ID: 15544875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
